Detection of the t(2;5)(p23;q35) chromosomal translocation in large B- cell lymphomas other than anaplastic large cell lymphoma

Human Pathology

Volumn 27, Issue 6, 1996, Pages 590-594

  Arber, Daniel A ^a   Sun, Li Hua ^a   Weiss, Lawrence M ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

CD30; large cell lymphoma; t(2; 5)

Indexed keywords

CD30 ANTIGEN; MESSENGER RNA; OLIGONUCLEOTIDE;

ADOLESCENT; ADULT; AGED; ANAPLASTIC CARCINOMA; ANTIGEN EXPRESSION; ARTICLE; B CELL LYMPHOMA; CHROMOSOME TRANSLOCATION; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CYTOGENETICS; FEMALE; GENE AMPLIFICATION; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARGE CELL LYMPHOMA; MALE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0029948504     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0046-8177(96)90167-7     Document Type: Article

References (34)

1. Morgan R, Hecht BK, Sandberg AA, et al: Chromosome 5q35 breakpoint in malignant histiocytosis. N Engl J Med 314:1322, 1986
2. Benz-Lemoine E, Brizard A, Huret J-L, et al: Malignant histiocytosis: A specific t(2;5) (p23;q35) translocation? Review of the literature. Blood 72:1045-1047, 1988
3. Rimokh R, Magaud J-P, Berger F, et al: A translocation involving a specific breakpoint (q35) on chromosome 5 is characteristic of anaplastic large cell lymphoma ("Ki-1 lymphoma"). Br J Haematol 71:31-36, 1989
4. LeBeau MM, Bitter MA, Larson RA, et al: The t(2;5) (p23;q35): A recurring chromosomal abnormality in Ki-1-positive anaplastic large cell lymphoma. Leukemia 3:866-870, 1989
5. Bitter MA, Franklin WA, Larson RA, et al: Morphology in Ki-1 (CD30)-positive non-Hodgkin's lymphoma is correlated with clinical features and the presence of a unique chromosomal abnormality, t(2;5)(p23;q35). AmJ Surg Pathol 14:305-316, 1990
6. Mason DY, Bastard C, Rimokh R, et al: CD30-positive large cell lymphomas ("Ki-1 lymphoma") are associated with a chromosomal translocation involving 5q35. Br J Haematol 74:161-168, 1990
7. Ebrahim SAD; Ladanyi M, Desai SB, et al: Immunohistochemical, molecular, and cytogenetic analysis of a consecutive series of 20 peripheral T-cell lymphomas and lymphomas of uncertain lineage, including 12 Ki-1 positive lymphomas. Genes Chromosomes Cancer 2:27-35, 1990
8. Morris SW, Kirstein MN, Valentine MB, et al: Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. Science 263:1281-1284, 1994
9. Wilson MS, Weiss LM, Gatter KC, et al: Malignant histiocytosis: A reassessment of cases previously reported in 1975 based on paraffin section immunophenotyping studies. Cancer 66:530-536, 1990
10. Keneko Y, Frizzera G, Edamura S, et al: A novel translocation, t(2;5)(p23;q35), in childhood phagocytic large T-cell lymphoma mimicking malignant histiocytosis. Blood 73:806-813, 1989
11. Stein H, Mason DY, GerdesJ, et al: The expression of Hodgkin's disease-associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: Evidence that Reed-Sternberg cell and histiocytic malignancies are derived from activated lymphoid cells. Blood 66:848-858, 1985
12. Bullrich F, Morris SW, Hummel M, et al: Nucleophosmin (NPM) gene rearrangements in Ki-1 positive lymphomas. Cancer Res 54:2873-2877, 1994
13. Orscheschek K, Mertz H, Hell J, et al: Large-cell anaplastic lymphoma-specific translocation (t[2;5][p23;q35]) in Hodgkin's disease: Indication of a common pathogenesis? Lancet 345:87-90, 1995
14. + lymphomas from American and Asian patients: A reverse transcriptase-polymerase chain reaction study. Am J Pathol 146:323-328, 1995
15. Weiss LM, Lopategui JR, Sun L-H, et al: Absence of the t(2; 5) in Hodgkin's disease. Blood 85:2845-2847, 1995
16. Morgan R, Smith SD, Hecht BK, et al: Lack of involvement of the c-fms and N-myc genes by chromosomal translocation t(2;5) (p23;q35) common to malignancies with features of so-called malignant histiocytosis. Blood 73:2155-2164, 1989
17. Sheibani K, Tubbs RR: Enzyme immunohistochemistry: Technical aspects. Semin Diagn Pathol 1:235-250, 1984
18. Gown AM, de Wever N, Battifora H: Microwave-based antigenic unmasking: A revolutionary new technique for routine immunohistochemistry. Appl Immunohistochem 1:256-266, 1993
19. Bloomfield CD, Arthur DC, Frizzera G, et al: Nonrandom chromosome abnormalities in lymphoma. Cancer Res 43:2975-2984, 1983
20. Pirc-Danoewinata H, Chott A, Onderka E, et al: Karyotype and prognosis in non-Hodgkin's lymphoma. Leukemia 8:1929-1939, 1994
21. Yunis JJ, Oken MM, Kaplan ME, et al: Distinctive chromosomal abnormalities in histologic subtypes of non-Hodgkin's lymphoma. N Engl J Med 307:1231-1236, 1982
22. Williams ME, Swerdlow SH, Rosenberg CL, et al: Characterization of chromosome 11 translocation breakpoints at the bcl-1 and PRAD1 loci in centrocytic lymphoma. Cancer Res 52:5541S-5544S, 1992 (suppl)
23. Leder P, Battey J, Lenior G, et al: Translocations among antibody genes in human cancer. Science 222:765-771, 1983
24. Ye BH, Lista F, Lo Coco F, et al: Alterations of a zinc fingerencoding gene, BCL-6, in diffuse large-cell lymphoma. Science 262:747-750, 1993
25. Herbst H, Stein H, Niedobitek G: Epstein-Barr virus and CD30+ malignant lymphomas. Crit Rev Oncol 4:191-239, 1993
26. Hsu SM, Yang K, Jaffe ES: Phenotypic expression of Hodgkin's and Reed-Sternberg cells in Hodgkin's disease. Am J Pathol 118:209-217, 1985
27. Stein H, GerdesJ, Schwab U: Identification of Hodgkin and Sternberg-Reed cells as a unique cell type derived from a newlydetected small-cell population. Int J Cancer 30:445-459, 1982
28. Shiota M, Fujimoto J, Takenaga M, et al: Diagnosis of t(2;5) (p23;q35)-associated Ki-1 lymphoma with immunohistochemistry. Blood 84:3648-3652, 1994
29. McBride JA, Luthra RL, Sarris AH, et al: Rearrangements of the NPM gene are selectively but infrequently associated with anaplastic large cell lymphoma (ALCL). Mod Pathol 8:116A, 1995 (abstr)
30. Ngan B: The presence of transcripts of the fusion of kinase gene ALK to nucleophosmin gene NPM in the t(2;5) (p23;q35) translocation defines subsets of non-Hodgkin's lymphoma with or without CD30 (Ki-1) expression and Hodgkin's disease. Mod Pathol 8:118A, 1995 (abstr)
31. Wellman A, Clark HM, Otsuki T, et al: Detection of the t(2;5)(p23;q35) in classical anaplastic large cell lymphoma (ALCL) by reverse transcriptase-polymerase chain reaction (RT-PCR). Mod Pathol 8:123A, 1995 (abstr)
32. Yee HT, Ponzoni M, Merson A, et al: Chimeric NPM-ALK transcripts of t(2;5) in anaplastic large cell lymphoma (ALCL) and Hodgkin's disease (HD). Mod Pathol 8:124A, 1995 (abstr)
33. Ladanyi M, Cavalchire G, Morris SW, et al: Reverse transcriptase polymerase chain reaction for the Ki-1 anaplastic large cell lymphoma-associated t(2;5) translocation in Hodgkin's disease. Am J Pathol 145:1296-1300, 1994
34. Downing J, Shurtleff S, Zielenska M, et al: Molecular detection of the t(2;5) translocation of non-Hodgkin's lymphoma by reverse transcriptase polymerase chain reaction. Blood 85:3416-3422, 1995